SENNA LAXATIVE

SENNA LAXATIVE was reported 1323 times

SENNA LAXATIVE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LABRAL RECONSTRUCTION 1 0.3333
1 ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY TEST POSITIVE 1 0.1429
2 LARYNGOSCOPY 1 0.0476
3 ELECTROCARDIOGRAM NORMAL 1 0.0357
4 BLADDER CATHETER REMOVAL 1 0.0357
5 INTRA-CEREBRAL ANEURYSM OPERATION 1 0.0263
6 BURKHOLDERIA TEST POSITIVE 3 0.0242
7 APNOEA TEST ABNORMAL 1 0.0208
8 OPTIC PERINEURITIS 1 0.0185
9 JUVENILE MYOCLONIC EPILEPSY 1 0.0159
10 LUNG ADENOCARCINOMA STAGE I 1 0.0139
11 JAUNDICE ACHOLURIC 1 0.0114
12 CARCINOID HEART DISEASE 1 0.0110
13 DEFICIENCY ANAEMIA 1 0.0105
14 MASTOID DISORDER 1 0.0101
15 MONONEUROPATHY 2 0.0096
16 WOUND INFECTION PSEUDOMONAS 3 0.0096
17 ARTIFICIAL MENOPAUSE 1 0.0094
18 POST THROMBOTIC SYNDROME 4 0.0089
19 PNEUMONIA ESCHERICHIA 3 0.0088
20 BREAST DISORDER MALE 1 0.0086
21 BIPOLAR II DISORDER 3 0.0083
22 CATHETER SITE THROMBOSIS 2 0.0073
23 CHOLELITHIASIS OBSTRUCTIVE 1 0.0060
24 HYPOCOMPLEMENTAEMIA 1 0.0059
25 PORTAL HYPERTENSIVE GASTROPATHY 3 0.0053
26 GASTROINTESTINAL EROSION 3 0.0047
27 EXPOSURE TO FUNGUS 1 0.0047
28 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
29 DRUG DELIVERY DEVICE IMPLANTATION 1 0.0045
30 LIPASE ABNORMAL 1 0.0045
31 CONGENITAL HIATUS HERNIA 1 0.0044
32 CHOLESTEROSIS 1 0.0039
33 NEUROGENIC SHOCK 2 0.0037
34 ARTERIAL STENT INSERTION 1 0.0037
35 COLONIC PSEUDO-OBSTRUCTION 1 0.0036
36 BURNS FIRST DEGREE 1 0.0035
37 EAR INFLAMMATION 1 0.0035
38 INJECTION SITE CYST 1 0.0034
39 PLASMA CELL LEUKAEMIA 2 0.0033
40 RECTOCELE 2 0.0033
41 NEOPLASM PROSTATE 1 0.0032
42 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
43 COMMINUTED FRACTURE 1 0.0030
44 CUBITAL TUNNEL SYNDROME 1 0.0029
45 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
46 FUNGAL TEST POSITIVE 1 0.0028
47 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
48 COLOUR BLINDNESS ACQUIRED 1 0.0028
49 DIET NONCOMPLIANCE 1 0.0027
50 METAPNEUMOVIRUS INFECTION 2 0.0026
51 INTESTINAL PROLAPSE 1 0.0024
52 CARDITIS 1 0.0024
53 MELANOMA RECURRENT 1 0.0024
54 ABDOMINAL CAVITY DRAINAGE 1 0.0024
55 APPARENT LIFE THREATENING EVENT 1 0.0024
56 CARBON MONOXIDE POISONING 1 0.0023
57 MUSCULAR DYSTROPHY 1 0.0023
58 SPINAL CORD NEOPLASM 2 0.0023
59 FUNGAL FOOT INFECTION 1 0.0023
60 OESOPHAGEAL INFECTION 1 0.0022
61 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
62 EATING DISORDER SYMPTOM 1 0.0022
63 MECHANICAL URTICARIA 1 0.0021
64 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
65 MYELOID LEUKAEMIA 1 0.0020
66 TESTICULAR DISORDER 2 0.0020
67 BREAST CONSERVING SURGERY 1 0.0020
68 CYST REMOVAL 1 0.0019
69 HOSPICE CARE 19 0.0019
70 INFUSION SITE VESICLES 1 0.0019
71 GRIEF REACTION 1 0.0019
72 BONE DEMINERALISATION 2 0.0019
73 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
74 TEMPERATURE REGULATION DISORDER 4 0.0018
75 OCCIPITAL NEURALGIA 1 0.0018
76 BURNING MOUTH SYNDROME 1 0.0018
77 NAIL BED BLEEDING 1 0.0018
78 COLON INJURY 1 0.0017
79 OPHTHALMIC HERPES SIMPLEX 1 0.0017
80 FULL BLOOD COUNT INCREASED 2 0.0017
81 GASTROINTESTINAL BACTERIAL OVERGROWTH 1 0.0017
82 RECTAL PROLAPSE 2 0.0017
83 ALLERGY TO METALS 1 0.0016
84 OPEN ANGLE GLAUCOMA 1 0.0016
85 PLASMACYTOMA 3 0.0016
86 NARCOLEPSY 3 0.0016
87 TUMOUR PAIN 2 0.0015
88 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
89 NASAL OPERATION 1 0.0015
90 ARACHNOIDITIS 1 0.0014
91 GRAVITATIONAL OEDEMA 1 0.0014
92 MAST CELL ACTIVATION SYNDROME 2 0.0014
93 FUNGAL OESOPHAGITIS 1 0.0014
94 APPLICATION SITE ULCER 1 0.0014
95 BRONCHIAL WALL THICKENING 1 0.0014
96 LIPIDS ABNORMAL 1 0.0014
97 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
98 HEART SOUNDS ABNORMAL 1 0.0013
99 GASTRIC POLYPS 3 0.0013
100 MYASTHENIC SYNDROME 1 0.0013
101 HAPTOGLOBIN DECREASED 1 0.0012
102 CAMPYLOBACTER INFECTION 1 0.0012
103 DENTAL DISCOMFORT 1 0.0012
104 MALIGNANT HYPERTENSION 1 0.0012
105 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
106 PRE-EXISTING CONDITION IMPROVED 7 0.0011
107 ABDOMINAL NEOPLASM 1 0.0011
108 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1 0.0011
109 METASTASES TO ADRENALS 1 0.0011
110 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
111 APPLICATION SITE DERMATITIS 1 0.0011
112 ENDOTRACHEAL INTUBATION 3 0.0011
113 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
114 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
115 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I 1 0.0010
116 HYPOGEUSIA 2 0.0010
117 VARICES OESOPHAGEAL 3 0.0010
118 GASTRIC PH DECREASED 1 0.0010
119 LIGHT CHAIN ANALYSIS INCREASED 1 0.0010
120 FOETAL DEATH 5 0.0010
121 RESPIRATORY RATE DECREASED 3 0.0010
122 METASTASES TO PLEURA 1 0.0010
123 ASTERIXIS 1 0.0009
124 KETOSIS 1 0.0009
125 INFUSION SITE MASS 1 0.0009
126 BIPOLAR I DISORDER 2 0.0009
127 CLOSTRIDIUM TEST POSITIVE 2 0.0009
128 CATHETER SITE DISCHARGE 1 0.0009
129 NEOPLASM RECURRENCE 3 0.0009
130 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
131 CORTISOL DECREASED 1 0.0009
132 NECK SURGERY 2 0.0009
133 ALLODYNIA 1 0.0009
134 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
135 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
136 GASTROINTESTINAL OBSTRUCTION 2 0.0008
137 LARGE INTESTINE INFECTION 1 0.0008
138 INTERVERTEBRAL DISC OPERATION 1 0.0008
139 FACE INJURY 3 0.0008
140 AMMONIA INCREASED 4 0.0008
141 ENURESIS 3 0.0007
142 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
143 PERIPHERAL VENOUS DISEASE 3 0.0007
144 CARBON DIOXIDE INCREASED 1 0.0007
145 BILIARY TRACT DISORDER 1 0.0007
146 CARDIOVERSION 1 0.0007
147 CATAPLEXY 1 0.0007
148 DIABETIC FOOT INFECTION 1 0.0007
149 INTENSIVE CARE 1 0.0007
150 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
151 VITAMIN B12 DECREASED 2 0.0007
152 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
153 LUMBAR SPINAL STENOSIS 2 0.0007
154 GENERALISED ANXIETY DISORDER 1 0.0007
155 HEART VALVE REPLACEMENT 1 0.0007
156 ARTHROPOD BITE 5 0.0007
157 BURSITIS 8 0.0007
158 INFECTIOUS PLEURAL EFFUSION 1 0.0007
159 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
160 DAYDREAMING 1 0.0006
161 PORTAL HYPERTENSION 2 0.0006
162 FOOD ALLERGY 5 0.0006
163 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
164 MEGACOLON 1 0.0006
165 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
166 COELIAC DISEASE 6 0.0006
167 INTESTINAL POLYP 1 0.0006
168 HYPERVOLAEMIA 3 0.0006
169 COLONIC POLYP 1 0.0006
170 POST-TRAUMATIC STRESS DISORDER 4 0.0006
171 MALIGNANT PLEURAL EFFUSION 1 0.0006
172 TOXIC ENCEPHALOPATHY 3 0.0006
173 REGURGITATION 2 0.0006
174 TACHYPHRENIA 2 0.0006
175 HYSTERECTOMY 5 0.0006
176 HAEMORRHAGIC DIATHESIS 2 0.0006
177 COMPRESSION FRACTURE 3 0.0006
178 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
179 DEVICE ALARM ISSUE 1 0.0006
180 ESSENTIAL HYPERTENSION 1 0.0005
181 BODY TEMPERATURE ABNORMAL 1 0.0005
182 INFECTED SKIN ULCER 1 0.0005
183 AUTOIMMUNE THYROIDITIS 2 0.0005
184 BONE MARROW TRANSPLANT 1 0.0005
185 SLEEP APNOEA SYNDROME 10 0.0005
186 HEPATIC MASS 1 0.0005
187 REHABILITATION THERAPY 2 0.0005
188 EARLY SATIETY 1 0.0005
189 MULTIPLE ALLERGIES 4 0.0005
190 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
191 COLOSTOMY 1 0.0005
192 OCCULT BLOOD POSITIVE 1 0.0005
193 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
194 TRIGEMINAL NEURALGIA 2 0.0005
195 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
196 DEVICE RELATED SEPSIS 1 0.0005
197 MUCOSAL DRYNESS 1 0.0005
198 FRUSTRATION TOLERANCE DECREASED 4 0.0005
199 DECUBITUS ULCER 4 0.0005
200 BREAST DISORDER 1 0.0005
201 NEUROGENIC BLADDER 1 0.0005
202 BLOOD TESTOSTERONE INCREASED 1 0.0005
203 DEREALISATION 1 0.0005
204 LYMPHOCYTOSIS 1 0.0005
205 ABSCESS INTESTINAL 1 0.0005
206 INFUSION SITE BRUISING 1 0.0005
207 APPLICATION SITE SCAB 1 0.0005
208 BLOOD COUNT ABNORMAL 7 0.0005
209 LIMB MASS 1 0.0005
210 ACCIDENT AT WORK 1 0.0005
211 CALCINOSIS 1 0.0004
212 FULL BLOOD COUNT DECREASED 9 0.0004
213 FEAR OF DEATH 1 0.0004
214 ANAL INCONTINENCE 4 0.0004
215 CHRONIC MYELOID LEUKAEMIA 2 0.0004
216 INFUSION SITE INFECTION 1 0.0004
217 HEPATIC ENCEPHALOPATHY 4 0.0004
218 RIGHT VENTRICULAR FAILURE 3 0.0004
219 SPINAL COLUMN STENOSIS 2 0.0004
220 SPINAL DISORDER 4 0.0004
221 COLORECTAL CANCER METASTATIC 1 0.0004
222 MYOPIA 1 0.0004
223 LONG QT SYNDROME 1 0.0004
224 NOCTURIA 5 0.0004
225 BRONCHITIS CHRONIC 1 0.0004
226 HAEMATOLOGICAL INFECTION 1 0.0004
227 CARTILAGE INJURY 1 0.0004
228 ABDOMINAL TENDERNESS 2 0.0004
229 IMMUNODEFICIENCY 6 0.0004
230 HYPERPARATHYROIDISM SECONDARY 1 0.0004
231 LABYRINTHITIS 1 0.0004
232 ENDODONTIC PROCEDURE 1 0.0004
233 ILEOSTOMY 1 0.0004
234 PHLEBITIS 2 0.0004
235 PERIPHERAL VASCULAR DISORDER 2 0.0004
236 MUSCULOSKELETAL CHEST PAIN 6 0.0004
237 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
238 CONCUSSION 3 0.0004
239 CONSTIPATION 84 0.0004
240 ATRIAL FLUTTER 3 0.0004
241 BODY HEIGHT DECREASED 4 0.0004
242 FOOD POISONING 2 0.0004
243 INJECTION SITE DISCHARGE 2 0.0004
244 GASTROINTESTINAL INJURY 1 0.0004
245 GAMBLING DISORDER 1 0.0004
246 CHEILITIS 2 0.0004
247 CLONUS 1 0.0004
248 HYPERAESTHESIA 3 0.0004
249 JAW DISORDER 2 0.0004
250 NONSPECIFIC REACTION 2 0.0004
251 PROSTATIC DISORDER 2 0.0004
252 HAEMORRHOIDS 7 0.0004
253 MALNUTRITION 4 0.0004
254 FIBULA FRACTURE 1 0.0003
255 LUNG CANCER METASTATIC 1 0.0003
256 DISEASE PROGRESSION 41 0.0003
257 FLUID OVERLOAD 5 0.0003
258 DEVICE POWER SOURCE ISSUE 1 0.0003
259 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
260 ATYPICAL PNEUMONIA 1 0.0003
261 METABOLIC ENCEPHALOPATHY 1 0.0003
262 PLASMA CELL MYELOMA 13 0.0003
263 LUNG ADENOCARCINOMA 1 0.0003
264 CRANIOCEREBRAL INJURY 1 0.0003
265 DERMATITIS ACNEIFORM 2 0.0003
266 MEDICAL DEVICE DISCOMFORT 1 0.0003
267 BRAIN NEOPLASM 3 0.0003
268 MENISCUS INJURY 2 0.0003
269 LARYNGEAL OEDEMA 2 0.0003
270 DIASTOLIC DYSFUNCTION 1 0.0003
271 INFUSION SITE PRURITUS 1 0.0003
272 GASTRIC ULCER 6 0.0003
273 CARDIAC FLUTTER 2 0.0003
274 HEPATIC NEOPLASM 1 0.0003
275 PRODUCT PREPARATION ISSUE 2 0.0003
276 INJECTION SITE INFECTION 1 0.0003
277 INFUSION SITE HAEMORRHAGE 1 0.0003
278 LIGAMENT SPRAIN 3 0.0003
279 NEAR DEATH EXPERIENCE 1 0.0003
280 SARS-COV-2 TEST POSITIVE 4 0.0003
281 UPPER LIMB FRACTURE 6 0.0003
282 TERMINAL STATE 2 0.0003
283 METASTASES TO SPINE 1 0.0003
284 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
285 SINUS CONGESTION 4 0.0003
286 RIB FRACTURE 6 0.0003
287 APLASIA PURE RED CELL 1 0.0003
288 LEFT VENTRICULAR FAILURE 1 0.0003
289 CERVICAL VERTEBRAL FRACTURE 1 0.0003
290 LYMPHOEDEMA 2 0.0003
291 PETECHIAE 3 0.0003
292 CAROTID ARTERY STENOSIS 1 0.0003
293 HANGOVER 1 0.0003
294 LOGORRHOEA 1 0.0003
295 NECROTISING FASCIITIS 1 0.0003
296 LUNG TRANSPLANT 1 0.0003
297 APPENDICECTOMY 1 0.0003
298 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
299 FACIAL BONES FRACTURE 1 0.0003
300 OSTEOMYELITIS 5 0.0003
301 BACK INJURY 3 0.0003
302 LIVER TRANSPLANT 1 0.0003
303 MAJOR DEPRESSION 2 0.0003
304 BLOOD PHOSPHORUS DECREASED 1 0.0003
305 AMYLASE INCREASED 1 0.0003
306 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
307 FEELING DRUNK 2 0.0003
308 EYE INFECTION 3 0.0003
309 CATHETER SITE INFECTION 1 0.0003
310 LOSS OF CONTROL OF LEGS 1 0.0003
311 INTERNAL HAEMORRHAGE 3 0.0003
312 COMMUNICATION DISORDER 1 0.0003
313 GASTRIC INFECTION 1 0.0003
314 CLAVICLE FRACTURE 1 0.0003
315 DISSOCIATION 2 0.0003
316 ACUTE RESPIRATORY FAILURE 5 0.0003
317 FAECES HARD 1 0.0003
318 ORAL INFECTION 1 0.0003
319 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
320 GINGIVAL PAIN 2 0.0003
321 OBESITY 4 0.0003
322 BLOOD DISORDER 2 0.0002
323 RHINITIS 2 0.0002
324 FUNGAL SKIN INFECTION 1 0.0002
325 APPLICATION SITE DISCOLOURATION 1 0.0002
326 HYPERSOMNIA 7 0.0002
327 METASTASES TO BONE 4 0.0002
328 HYPERCALCAEMIA 3 0.0002
329 SPINAL COMPRESSION FRACTURE 2 0.0002
330 ACUTE CORONARY SYNDROME 2 0.0002
331 AORTIC VALVE INCOMPETENCE 1 0.0002
332 RETCHING 5 0.0002
333 METASTATIC NEOPLASM 1 0.0002
334 BLOOD MAGNESIUM DECREASED 2 0.0002
335 BONE CANCER 1 0.0002
336 ANHEDONIA 6 0.0002
337 BEDRIDDEN 3 0.0002
338 DYSPHEMIA 1 0.0002
339 ONYCHOMYCOSIS 1 0.0002
340 METASTASES TO LIVER 4 0.0002
341 HAEMORRHAGIC ANAEMIA 1 0.0002
342 TUMOUR LYSIS SYNDROME 2 0.0002
343 IMMUNOSUPPRESSION 2 0.0002
344 CATHETERISATION CARDIAC 1 0.0002
345 BRAIN NEOPLASM MALIGNANT 1 0.0002
346 IRON DEFICIENCY 1 0.0002
347 GASTROENTERITIS VIRAL 4 0.0002
348 HEART RATE IRREGULAR 5 0.0002
349 HEAD INJURY 7 0.0002
350 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
351 RESTLESS LEGS SYNDROME 4 0.0002
352 HYPOTHYROIDISM 7 0.0002
353 EXOSTOSIS 2 0.0002
354 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
355 HIP FRACTURE 7 0.0002
356 NIGHT SWEATS 7 0.0002
357 EYE OPERATION 1 0.0002
358 UROSEPSIS 2 0.0002
359 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
360 MENTAL STATUS CHANGES 6 0.0002
361 NEPHROGENIC ANAEMIA 1 0.0002
362 ORAL DISCOMFORT 3 0.0002
363 BLOOD TEST ABNORMAL 3 0.0002
364 DYSPNOEA EXERTIONAL 8 0.0002
365 HALLUCINATION 16 0.0002
366 BLOOD SODIUM DECREASED 4 0.0002
367 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
368 DIALYSIS 3 0.0002
369 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
370 URINARY TRACT INFECTION 36 0.0002
371 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
372 ENTEROCOCCAL INFECTION 1 0.0002
373 LOCALISED INFECTION 5 0.0002
374 FINGER DEFORMITY 1 0.0002
375 PLATELET COUNT DECREASED 22 0.0002
376 FIBROMYALGIA 5 0.0002
377 NEURALGIA 5 0.0002
378 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
379 FOOT OPERATION 1 0.0002
380 HYPERNATRAEMIA 1 0.0002
381 AGEUSIA 5 0.0002
382 PNEUMONIA ASPIRATION 5 0.0002
383 BLOOD POTASSIUM DECREASED 6 0.0002
384 BRAIN INJURY 2 0.0002
385 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
386 DRUG TOLERANCE 1 0.0002
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
388 FEEDING DISORDER 4 0.0002
389 TASTE DISORDER 4 0.0002
390 DYSLIPIDAEMIA 1 0.0002
391 HYPOPHAGIA 5 0.0002
392 HOSPITALISATION 30 0.0002
393 ENDOCARDITIS 1 0.0002
394 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
395 SKIN ULCER 5 0.0002
396 POOR VENOUS ACCESS 2 0.0002
397 LUNG INFECTION 3 0.0002
398 RASH GENERALISED 5 0.0002
399 HYPERBILIRUBINAEMIA 2 0.0002
400 HAEMATOMA 5 0.0002
401 BONE DENSITY DECREASED 6 0.0002
402 BLOOD PRESSURE INCREASED 29 0.0002
403 HALLUCINATION, VISUAL 4 0.0002
404 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
405 RENAL PAIN 2 0.0002
406 ANORECTAL DISCOMFORT 1 0.0002
407 BREAST PAIN 2 0.0002
408 ANAL FISSURE 1 0.0002
409 POOR QUALITY SLEEP 4 0.0002
410 BRUXISM 1 0.0002
411 THROAT TIGHTNESS 5 0.0002
412 SEPTIC SHOCK 8 0.0002
413 PULMONARY THROMBOSIS 2 0.0002
414 FAECALOMA 1 0.0002
415 RESPIRATORY DISTRESS 5 0.0002
416 CYSTIC FIBROSIS 1 0.0002
417 DIVERTICULITIS 5 0.0002
418 TOOTH DISORDER 4 0.0002
419 HEART RATE ABNORMAL 1 0.0002
420 ABDOMINAL DISCOMFORT 30 0.0002
421 PULMONARY OEDEMA 8 0.0002
422 SNEEZING 4 0.0002
423 SKIN INFECTION 2 0.0002
424 BLISTER 10 0.0002
425 BLOOD CALCIUM DECREASED 2 0.0002
426 MITRAL VALVE INCOMPETENCE 2 0.0002
427 GENERALISED ERYTHEMA 1 0.0002
428 DERMATITIS CONTACT 2 0.0002
429 CARDIAC VALVE DISEASE 1 0.0002
430 NEPHROLITHIASIS 8 0.0002
431 PARANOIA 3 0.0002
432 LETHARGY 10 0.0002
433 UNINTENTIONAL MEDICAL DEVICE REMOVAL 2 0.0002
434 WEIGHT DECREASED 48 0.0002
435 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
436 HYPOVOLAEMIA 1 0.0002
437 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
438 DECREASED INTEREST 1 0.0002
439 LABORATORY TEST ABNORMAL 5 0.0002
440 COVID-19 PNEUMONIA 2 0.0002
441 URINARY INCONTINENCE 5 0.0002
442 BACTERAEMIA 2 0.0002
443 FATIGUE 131 0.0002
444 CARDIAC PACEMAKER INSERTION 1 0.0002
445 ODYNOPHAGIA 1 0.0002
446 GOUT 3 0.0002
447 WRIST FRACTURE 2 0.0002
448 WITHDRAWAL SYNDROME 7 0.0002
449 LEUKOCYTOSIS 3 0.0002
450 DEHYDRATION 22 0.0002
451 PANIC ATTACK 6 0.0002
452 INGUINAL HERNIA 1 0.0002
453 VERTIGO 10 0.0002
454 PNEUMONIA 53 0.0002
455 FEELING HOT 10 0.0002
456 ABDOMINAL DISTENSION 17 0.0002
457 DYSPEPSIA 16 0.0002
458 FALL 54 0.0002
459 CHOLANGITIS 1 0.0002
460 CYST 2 0.0002
461 OLIGURIA 1 0.0002
462 BACTERIAL INFECTION 3 0.0002
463 SECRETION DISCHARGE 2 0.0002
464 DECREASED APPETITE 37 0.0002
465 BACK PAIN 37 0.0002
466 INFUSION SITE SWELLING 1 0.0002
467 CELLULITIS 8 0.0002
468 FOOT FRACTURE 3 0.0002
469 FEELING JITTERY 3 0.0002
470 FLUID RETENTION 8 0.0002
471 FOREIGN BODY SENSATION IN EYES 1 0.0002
472 PULMONARY FIBROSIS 3 0.0002
473 ENTERITIS 1 0.0002
474 CHOLESTASIS 3 0.0002
475 LOWER LIMB FRACTURE 3 0.0002
476 THERAPY CESSATION 8 0.0002
477 INFUSION SITE PAIN 2 0.0002
478 PRESCRIBED OVERDOSE 3 0.0002
479 UNRESPONSIVE TO STIMULI 4 0.0002
480 INCOHERENT 1 0.0002
481 HERPES SIMPLEX 1 0.0002
482 MEMORY IMPAIRMENT 21 0.0002
483 SPEECH DISORDER 8 0.0002
484 ASPERGILLUS INFECTION 1 0.0002
485 IMMUNE SYSTEM DISORDER 2 0.0002
486 HAEMATOCRIT DECREASED 3 0.0002
487 APPETITE DISORDER 1 0.0002
488 RENAL DISORDER 7 0.0002
489 URINARY RETENTION 5 0.0001
490 CHOLECYSTITIS CHRONIC 1 0.0001
491 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
492 INTENTIONAL SELF-INJURY 3 0.0001
493 STOMATITIS 9 0.0001
494 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
495 BLOOD BILIRUBIN INCREASED 4 0.0001
496 DYSPHAGIA 14 0.0001
497 HYPERHIDROSIS 19 0.0001
498 NEUROPATHY PERIPHERAL 14 0.0001
499 IMPAIRED GASTRIC EMPTYING 2 0.0001
500 HOT FLUSH 11 0.0001
501 OSTEOPOROSIS 6 0.0001
502 CONTUSION 14 0.0001
503 ONYCHOCLASIS 1 0.0001
504 JOINT EFFUSION 1 0.0001
505 DRUG INTOLERANCE 14 0.0001
506 DROOLING 1 0.0001
507 TOOTH LOSS 3 0.0001
508 ENCEPHALITIS 1 0.0001
509 HAIR GROWTH ABNORMAL 1 0.0001
510 DELIRIUM 5 0.0001
511 LARGE INTESTINE PERFORATION 1 0.0001
512 NEOPLASM PROGRESSION 5 0.0001
513 ROAD TRAFFIC ACCIDENT 6 0.0001
514 HAEMOPTYSIS 4 0.0001
515 DERMATITIS 3 0.0001
516 CARPAL TUNNEL SYNDROME 2 0.0001
517 PERIPHERAL SWELLING 22 0.0001
518 HYPOXIA 5 0.0001
519 SEASONAL ALLERGY 2 0.0001
520 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
521 ASTHENIA 53 0.0001
522 EATING DISORDER 3 0.0001
523 DIVERTICULUM 1 0.0001
524 JOINT INJURY 3 0.0001
525 BRONCHOSPASM 2 0.0001
526 RED BLOOD CELL COUNT DECREASED 4 0.0001
527 PARAESTHESIA ORAL 2 0.0001
528 DEEP VEIN THROMBOSIS 9 0.0001
529 FAECES DISCOLOURED 3 0.0001
530 ANOSMIA 2 0.0001
531 HYPOKINESIA 2 0.0001
532 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
533 INTENTIONAL PRODUCT MISUSE 12 0.0001
534 DYSSTASIA 4 0.0001
535 INTENTIONAL UNDERDOSE 1 0.0001
536 BONE PAIN 8 0.0001
537 SURGERY 8 0.0001
538 NASAL CONGESTION 8 0.0001
539 DYSURIA 5 0.0001
540 HYPOPHOSPHATAEMIA 1 0.0001
541 CEREBRAL DISORDER 1 0.0001
542 BRONCHITIS 10 0.0001
543 SEPSIS 15 0.0001
544 COLON CANCER 2 0.0001
545 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
546 THROAT IRRITATION 6 0.0001
547 CHROMATURIA 3 0.0001
548 HYPOAESTHESIA ORAL 2 0.0001
549 NAUSEA 105 0.0001
550 APHASIA 4 0.0001
551 DEATH 114 0.0001
552 HEPATIC ENZYME INCREASED 9 0.0001
553 ECONOMIC PROBLEM 2 0.0001
554 OSTEOPENIA 2 0.0001
555 PRODUCT AVAILABILITY ISSUE 3 0.0001
556 AORTIC ANEURYSM 1 0.0001
557 ACIDOSIS 1 0.0001
558 BOWEL MOVEMENT IRREGULARITY 1 0.0001
559 SYNCOPE 13 0.0001
560 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
561 HAEMOLYSIS 1 0.0001
562 FEMUR FRACTURE 4 0.0001
563 DELUSION 2 0.0001
564 EJECTION FRACTION DECREASED 2 0.0001
565 NICOTINE DEPENDENCE 1 0.0001
566 BRAIN FOG 2 0.0001
567 FURUNCLE 1 0.0001
568 NASAL DISCOMFORT 1 0.0001
569 PNEUMOTHORAX 2 0.0001
570 THERAPY INTERRUPTED 9 0.0001
571 RESPIRATORY TRACT CONGESTION 2 0.0001
572 ULCER 2 0.0001
573 RASH ERYTHEMATOUS 6 0.0001
574 SCIATICA 2 0.0001
575 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
576 CARDIAC FAILURE CONGESTIVE 10 0.0001
577 MUSCLE DISORDER 1 0.0001
578 BLOOD POTASSIUM INCREASED 2 0.0001
579 NEUTROPHIL COUNT DECREASED 5 0.0001
580 ENCEPHALOPATHY 3 0.0001
581 ABNORMAL FAECES 1 0.0001
582 IMPAIRED HEALING 4 0.0001
583 OSTEONECROSIS 4 0.0001
584 MULTIPLE FRACTURES 2 0.0001
585 MANIA 2 0.0001
586 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
587 EOSINOPHIL COUNT INCREASED 1 0.0001
588 GAIT INABILITY 4 0.0001
589 HAEMODIALYSIS 1 0.0001
590 CANDIDA INFECTION 2 0.0001
591 GASTRIC DISORDER 4 0.0001
592 ANURIA 1 0.0001
593 DIARRHOEA 75 0.0001
594 MUSCLE STRAIN 1 0.0001
595 DRUG DOSE OMISSION 19 0.0001
596 MUCOSAL INFLAMMATION 3 0.0001
597 MUSCLE SPASMS 21 0.0001
598 RASH MACULAR 4 0.0001
599 SOMNOLENCE 23 0.0001
600 NEUROTOXICITY 2 0.0001
601 GASTRITIS 3 0.0001
602 GRIP STRENGTH DECREASED 1 0.0001
603 LUNG INFILTRATION 1 0.0001
604 HEAD DISCOMFORT 2 0.0001
605 GALLBLADDER DISORDER 2 0.0001
606 THROMBOSIS 9 0.0001
607 HAEMOLYTIC ANAEMIA 1 0.0001
608 HEAVY MENSTRUAL BLEEDING 1 0.0001
609 TOOTHACHE 2 0.0001
610 NEUTROPENIA 15 0.0001
611 PNEUMONITIS 3 0.0001
612 TREATMENT NONCOMPLIANCE 6 0.0001
613 END STAGE RENAL DISEASE 2 0.0001
614 SKIN LESION 3 0.0001
615 SKIN DISCOLOURATION 5 0.0001
616 INCREASED TENDENCY TO BRUISE 1 0.0001
617 NERVE COMPRESSION 1 0.0001
618 RHINORRHOEA 7 0.0001
619 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
620 FEELING COLD 3 0.0001
621 NECK PAIN 6 0.0001
622 DEMENTIA 3 0.0001
623 NEPHROPATHY 1 0.0001
624 COGNITIVE DISORDER 5 0.0001
625 DEFORMITY 1 0.0001
626 EPISTAXIS 8 0.0001
627 ABDOMINAL PAIN UPPER 22 0.0001
628 SWELLING 10 0.0001
629 FLANK PAIN 1 0.0001
630 HYPONATRAEMIA 6 0.0001
631 INTESTINAL OBSTRUCTION 4 0.0001
632 FLATULENCE 6 0.0001
633 INFUSION RELATED REACTION 7 0.0001
634 MUSCULAR WEAKNESS 12 0.0001
635 MUSCULOSKELETAL DISORDER 2 0.0001
636 VOMITING 49 0.0001
637 POST PROCEDURAL COMPLICATION 2 0.0001
638 BLOOD GLUCOSE DECREASED 5 0.0001
639 HYPERTENSION 22 0.0001
640 HYPERCHOLESTEROLAEMIA 1 0.0001
641 ATELECTASIS 1 0.0001
642 HERNIA 2 0.0001
643 ERUCTATION 2 0.0001
644 ORAL HERPES 2 0.0001
645 PYREXIA 35 0.0001
646 RENAL INJURY 3 0.0001
647 ABNORMAL BEHAVIOUR 4 0.0001
648 BLADDER DISORDER 1 0.0001
649 INABILITY TO AFFORD MEDICATION 1 0.0001
650 GASTROINTESTINAL DISORDER 9 0.0001
651 BURNING SENSATION 7 0.0001
652 SPINAL FRACTURE 2 0.0001
653 CONFUSIONAL STATE 16 0.0001
654 ABDOMINAL PAIN 23 0.0001
655 DRY THROAT 1 0.0001
656 ANXIETY 28 0.0001
657 FLUSHING 10 0.0001
658 THROMBOCYTOPENIA 11 0.0001
659 DIZZINESS 49 0.0001
660 MOTOR DYSFUNCTION 1 0.0001
661 PAIN 60 0.0001
662 NASOPHARYNGITIS 18 0.0001
663 INSOMNIA 26 0.0001
664 INITIAL INSOMNIA 1 0.0001
665 MOBILITY DECREASED 7 0.0001
666 ASTHMA 11 0.0001
667 HELICOBACTER INFECTION 1 0.0001
668 OROPHARYNGEAL PAIN 9 0.0001
669 COVID-19 17 0.0001
670 INFECTION 14 0.0001
671 EYE DISCHARGE 1 0.0001
672 SWOLLEN TONGUE 3 0.0001
673 PULMONARY HYPERTENSION 2 0.0001
674 RESPIRATORY FAILURE 7 0.0001
675 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
676 ECZEMA 5 0.0001
677 PRODUCT DOSE OMISSION ISSUE 28 0.0001
678 KNEE ARTHROPLASTY 2 0.0001
679 INCONTINENCE 1 0.0001
680 FULL BLOOD COUNT ABNORMAL 1 0.0001
681 CYSTITIS 3 0.0001
682 LOSS OF CONSCIOUSNESS 12 0.0001
683 HEREDITARY ANGIOEDEMA 1 0.0001
684 LIVER FUNCTION TEST INCREASED 2 0.0001
685 DECREASED ACTIVITY 1 0.0001
686 LACTIC ACIDOSIS 3 0.0001
687 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
688 OEDEMA 5 0.0001
689 BIPOLAR DISORDER 1 0.0001
690 PRODUCT DOSE OMISSION 6 0.0001
691 RASH 40 0.0001
692 OESOPHAGITIS 1 0.0001
693 MUSCULOSKELETAL STIFFNESS 8 0.0001
694 ASPIRATION 1 0.0001
695 GASTROINTESTINAL PAIN 1 0.0001
696 MELAENA 2 0.0001
697 FOOT DEFORMITY 1 0.0001
698 TRANSAMINASES INCREASED 2 0.0001
699 DRY SKIN 12 0.0001
700 GLOSSODYNIA 2 0.0001
701 ORAL PAIN 2 0.0001
702 INTESTINAL PERFORATION 1 0.0001
703 OCULAR DISCOMFORT 1 0.0001
704 IMPAIRED DRIVING ABILITY 1 0.0001
705 CHEST DISCOMFORT 9 0.0001
706 SINUSITIS 9 0.0001
707 MICTURITION URGENCY 1 0.0001
708 SUICIDAL IDEATION 8 0.0001
709 ILLNESS 9 0.0001
710 TINNITUS 4 0.0001
711 HYPOAESTHESIA 13 0.0001
712 HYPOKALAEMIA 4 0.0001
713 METASTASES TO LUNG 1 0.0001
714 DYSPHONIA 5 0.0001
715 MALAISE 37 0.0001
716 BLOOD IRON DECREASED 1 0.0001
717 CATARACT 5 0.0001
718 MYOCLONUS 1 0.0001
719 MACULAR DEGENERATION 1 0.0001
720 HYPERLIPIDAEMIA 1 0.0001
721 MUSCLE RIGIDITY 1 0.0001
722 DEPRESSION 19 0.0001
723 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
724 RENAL FAILURE 11 0.0001
725 ADRENAL INSUFFICIENCY 1 0.0001
726 PRESYNCOPE 2 0.0001
727 CONDITION AGGRAVATED 25 0.0001
728 PLEURAL EFFUSION 5 0.0001
729 CYTOPENIA 1 0.0001
730 PAIN IN EXTREMITY 24 0.0001
731 CARDIOMEGALY 1 0.0001
732 INJECTION SITE EXTRAVASATION 1 0.0001
733 HEART RATE INCREASED 8 0.0001
734 EYE SWELLING 3 0.0001
735 ILEUS 1 0.0001
736 DRY EYE 4 0.0001
737 INJECTION SITE DISCOLOURATION 1 0.0001
738 LEUKOPENIA 4 0.0001
739 DYSARTHRIA 3 0.0001
740 DERMATITIS ALLERGIC 1 0.0001
741 COLITIS 3 0.0001
742 CHRONIC KIDNEY DISEASE 6 0.0001
743 TACHYCARDIA 7 0.0001
744 TREMOR 13 0.0001
745 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
746 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
747 HAEMOGLOBIN DECREASED 8 0.0001
748 ERECTILE DYSFUNCTION 2 0.0001
749 ERYTHEMA 16 0.0001
750 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
751 ANAPHYLACTIC SHOCK 2 0.0001
752 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
753 HIATUS HERNIA 1 0.0001
754 INJECTION SITE INDURATION 1 0.0001
755 PSORIASIS 10 0.0001
756 NERVOUSNESS 4 0.0001
757 MYALGIA 13 0.0001
758 ADVERSE EVENT 7 0.0001
759 DISORIENTATION 3 0.0001
760 DYSMENORRHOEA 1 0.0001
761 BRADYCARDIA 4 0.0001
762 EAR INFECTION 2 0.0001
763 FEELING ABNORMAL 18 0.0001
764 DISTURBANCE IN ATTENTION 4 0.0001
765 FREQUENT BOWEL MOVEMENTS 2 0.0001
766 DRY MOUTH 6 0.0001
767 OEDEMA PERIPHERAL 9 0.0001
768 DYSKINESIA 3 0.0001
769 ANAEMIA 14 0.0001
770 MOOD ALTERED 2 0.0001
771 GINGIVAL BLEEDING 1 0.0001
772 GAIT DISTURBANCE 14 0.0001
773 PRURITUS 28 0.0001
774 DYSPNOEA 41 0.0001
775 TREATMENT FAILURE 6 0.0001
776 ARTHRALGIA 30 0.0001
777 POLLAKIURIA 3 0.0001
778 HUNGER 1 0.0001
779 COORDINATION ABNORMAL 1 0.0001
780 SLEEP DISORDER 5 0.0001
781 OSTEOARTHRITIS 3 0.0001
782 ANGINA PECTORIS 2 0.0001
783 HYPOTENSION 14 0.0001
784 OFF LABEL USE 61 0.0001
785 BALANCE DISORDER 6 0.0001
786 PANCREATIC CARCINOMA 2 0.0001
787 MYELODYSPLASTIC SYNDROME 1 0.0001
788 HYPERTHYROIDISM 1 0.0001
789 MENTAL DISORDER 3 0.0001
790 APATHY 1 0.0001
791 CHILLS 8 0.0001
792 ASCITES 2 0.0001
793 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
794 WHEEZING 4 0.0001
795 DYSGEUSIA 5 0.0001
796 HAEMORRHAGE INTRACRANIAL 1 0.0001
797 RESPIRATORY DISORDER 2 0.0001
798 ADVERSE DRUG REACTION 6 0.0001
799 BONE LOSS 1 0.0001
800 IRRITABILITY 4 0.0001
801 HEPATIC FAILURE 2 0.0001
802 JOINT SWELLING 8 0.0001
803 UNEVALUABLE EVENT 5 0.0001
804 CORONARY ARTERY DISEASE 2 0.0001
805 ILL-DEFINED DISORDER 4 0.0001
806 DEVICE FAILURE 1 0.0001
807 DIABETES MELLITUS 5 0.0001
808 SKIN IRRITATION 3 0.0001
809 INSURANCE ISSUE 1 0.0001
810 HEADACHE 41 0.0001
811 HIP ARTHROPLASTY 1 0.0001
812 DEVICE RELATED INFECTION 1 0.0001
813 CHEST PAIN 12 0.0001
814 LYMPHOMA 1 0.0001
815 HYPERSENSITIVITY 12 0.0001
816 VISUAL IMPAIRMENT 8 0.0001
817 EXPOSURE DURING PREGNANCY 4 0.0001
818 CARDIAC DISORDER 6 0.0001
819 BASAL CELL CARCINOMA 1 0.0001
820 ARTHRITIS 5 0.0001
821 HYPOGLYCAEMIA 3 0.0001
822 MUSCLE TIGHTNESS 1 0.0001
823 RHEUMATOID ARTHRITIS 7 0.0001
824 ATRIAL FIBRILLATION 6 0.0001
825 BACK DISORDER 1 0.0001
826 BLOOD CREATININE INCREASED 4 0.0001
827 ALOPECIA 12 0.0001
828 CHOLELITHIASIS 2 0.0001
829 STAPHYLOCOCCAL INFECTION 2 0.0001
830 COUGH 17 0.0001
831 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
832 DRUG LEVEL INCREASED 1 0.0001
833 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
834 BLOOD PRESSURE DECREASED 4 0.0001
835 EXPIRED PRODUCT ADMINISTERED 2 0.0001
836 VIRAL INFECTION 2 0.0001
837 LIP SWELLING 2 0.0001
838 COAGULOPATHY 1 0.0001
839 FUNGAL INFECTION 2 0.0001
840 AGGRESSION 3 0.0001
841 PALPITATIONS 7 0.0001
842 SKIN EXFOLIATION 5 0.0001
843 CEREBROVASCULAR ACCIDENT 10 0.0001
844 ACUTE KIDNEY INJURY 9 0.0001
845 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
846 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
847 MUSCULOSKELETAL DISCOMFORT 1 0.0001
848 EMOTIONAL DISTRESS 7 0.0001
849 NIGHTMARE 2 0.0001
850 HAEMORRHAGE 6 0.0001
851 PARAESTHESIA 9 0.0001
852 INJURY 4 0.0001
853 PANCREATITIS 3 0.0001
854 DEPRESSED MOOD 3 0.0001
855 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
856 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
857 LYMPHADENOPATHY 2 0.0001
858 PRODUCT ADHESION ISSUE 2 0.0001
859 CEREBRAL HAEMORRHAGE 2 0.0001
860 SKIN BURNING SENSATION 4 0.0001
861 RASH PRURITIC 3 0.0001
862 DRUG EFFECT INCOMPLETE 2 0.0001
863 CRYING 2 0.0001
864 RESTLESSNESS 2 0.0001
865 AGITATION 4 0.0001
866 HAEMATOCHEZIA 3 0.0001
867 BLOOD GLUCOSE ABNORMAL 1 0.0001
868 ARTHROPATHY 3 0.0001
869 INFLUENZA 6 0.0001
870 PANCYTOPENIA 3 0.0001
871 MIDDLE INSOMNIA 1 0.0001
872 HEPATIC CIRRHOSIS 1 0.0001
873 PRODUCT USE ISSUE 10 0.0001
874 HYPOCALCAEMIA 1 0.0001
875 FRACTURE 1 0.0001
876 DYSTONIA 1 0.0001
877 CHOKING 1 0.0001
878 KIDNEY INFECTION 1 0.0001
879 DISABILITY 1 0.0001
880 BLOOD PRESSURE ABNORMAL 1 0.0001
881 CYTOKINE RELEASE SYNDROME 1 0.0000
882 CARDIAC FAILURE 4 0.0000
883 NO ADVERSE EVENT 9 0.0000
884 EXTRA DOSE ADMINISTERED 2 0.0000
885 PSORIATIC ARTHROPATHY 2 0.0000
886 BONE MARROW FAILURE 1 0.0000
887 LUNG NEOPLASM MALIGNANT 2 0.0000
888 INFLUENZA LIKE ILLNESS 4 0.0000
889 IRRITABLE BOWEL SYNDROME 1 0.0000
890 RECTAL HAEMORRHAGE 2 0.0000
891 HYPOACUSIS 2 0.0000
892 AMNESIA 3 0.0000
893 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
894 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
895 FEBRILE NEUTROPENIA 3 0.0000
896 LIVER DISORDER 2 0.0000
897 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
898 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
899 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
900 APPLICATION SITE PRURITUS 1 0.0000
901 MUSCLE TWITCHING 1 0.0000
902 SEIZURE 5 0.0000
903 BLOOD GLUCOSE INCREASED 8 0.0000
904 ARRHYTHMIA 2 0.0000
905 OCULAR HYPERAEMIA 2 0.0000
906 PULMONARY EMBOLISM 4 0.0000
907 MIGRAINE 4 0.0000
908 PRODUCTIVE COUGH 2 0.0000
909 MULTIPLE SCLEROSIS 2 0.0000
910 BLOOD PRESSURE FLUCTUATION 1 0.0000
911 MENTAL IMPAIRMENT 1 0.0000
912 CEREBRAL INFARCTION 1 0.0000
913 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
914 WEIGHT INCREASED 9 0.0000
915 ACNE 3 0.0000
916 INJECTION SITE SWELLING 3 0.0000
917 DRUG INEFFECTIVE 51 0.0000
918 EXPOSURE VIA SKIN CONTACT 1 0.0000
919 DIPLOPIA 1 0.0000
920 APPLICATION SITE ERYTHEMA 1 0.0000
921 JOINT STIFFNESS 1 0.0000
922 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
923 BREAST CANCER FEMALE 1 0.0000
924 JAUNDICE 1 0.0000
925 DRUG EFFECT DECREASED 2 0.0000
926 OVERDOSE 8 0.0000
927 LIMB INJURY 1 0.0000
928 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
929 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
930 VISION BLURRED 5 0.0000
931 CARDIAC ARREST 3 0.0000
932 ANAPHYLACTIC REACTION 2 0.0000
933 URTICARIA 6 0.0000
934 OXYGEN SATURATION DECREASED 2 0.0000
935 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
936 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
937 INTENTIONAL DOSE OMISSION 1 0.0000
938 HERPES ZOSTER 2 0.0000
939 EYE IRRITATION 2 0.0000
940 MYOCARDIAL INFARCTION 6 0.0000
941 LIVER FUNCTION TEST ABNORMAL 1 0.0000
942 NEEDLE ISSUE 1 0.0000
943 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
944 DRUG WITHDRAWAL SYNDROME 3 0.0000
945 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
946 ACUTE MYOCARDIAL INFARCTION 1 0.0000
947 DEVICE ISSUE 3 0.0000
948 LACRIMATION INCREASED 1 0.0000
949 THERAPEUTIC RESPONSE DECREASED 2 0.0000
950 DISCOMFORT 2 0.0000
951 EPILEPSY 1 0.0000
952 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
953 INJECTION SITE ERYTHEMA 4 0.0000
954 NERVOUS SYSTEM DISORDER 1 0.0000
955 METABOLIC ACIDOSIS 1 0.0000
956 DRUG DEPENDENCE 5 0.0000
957 NEOPLASM MALIGNANT 2 0.0000
958 INJECTION SITE PRURITUS 2 0.0000
959 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
960 ANGER 1 0.0000
961 HAEMATURIA 1 0.0000
962 HEART RATE DECREASED 1 0.0000
963 DEVICE MALFUNCTION 2 0.0000
964 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
966 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
967 HYPERGLYCAEMIA 1 0.0000
968 UNDERDOSE 2 0.0000
969 INJECTION SITE MASS 1 0.0000
970 INCORRECT DOSE ADMINISTERED 6 0.0000
971 DRUG DOSE OMISSION BY DEVICE 2 0.0000
972 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
973 DRUG INTERACTION 4 0.0000
974 INJECTION SITE BRUISING 2 0.0000
975 BLINDNESS 1 0.0000
976 DRUG ABUSE 2 0.0000
977 DEVICE DISLOCATION 1 0.0000
978 PRODUCT STORAGE ERROR 2 0.0000
979 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
980 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
981 DISEASE RECURRENCE 1 0.0000
982 COMA 1 0.0000
983 INTERSTITIAL LUNG DISEASE 1 0.0000
984 LUNG DISORDER 1 0.0000
985 MUSCULOSKELETAL PAIN 1 0.0000
986 DERMATITIS ATOPIC 1 0.0000
987 MEDICATION ERROR 1 0.0000
988 INJECTION SITE PAIN 4 0.0000
989 INJECTION SITE HAEMORRHAGE 1 0.0000
990 TOXICITY TO VARIOUS AGENTS 2 0.0000
991 BREAST CANCER 1 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000